BD Phoenix meropenem-vaborbactam panel

Tuesday, 10 April, 2018 | Supplied by: BD


BD has introduced the ability to execute in vitro rapid identification (ID) and antimicrobial susceptibility testing (AST) for meropenem-vaborbactam in its latest panel for the BD Phoenix Automated Microbiology System, which detects resistance in Enterobacteriaceae, Non-Enterobacteriaceae and most gram-positive bacteria isolates from pure culture belonging to the genera Staphylococcus, Enterococcus and Streptococcus.

The BD Phoenix offers clinical microbiology laboratories the ability to rapidly test antimicrobial resistances or susceptibilities. The company’s rapid results for ID and AST are powered through an oxidation-reduction indicator with turbidity measurement for growth detection, as well as full on-panel antimicrobial concentrations and the BDXpert system for data analysis.

Online: www.bd.com
Phone: 02 8875 7000
Related Products

Dojindo Cell Counting Kit-8 (CCK-8)

The Cell Counting Kit-8 (CCK-8) from Dojindo is a pre-mixed, nonradioactive one-bottle solution...

Cayman Chemical Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit

Cayman Chemical's Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit provides a...

Sphere Fluidics Cyto-Mine single-cell analysis system for cell line development

Sphere Fluidics' Cyto-Mine is a single-cell analysis platform that enables individual cells...


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd